
247.89 Delayed Data As of Jul 05 | ![]() Today’s Change | 229.24 Today|||52-Week Range 277.29 | +1.11% Year-to-Date |
Rempart Asset Management Inc. Goes on Buying Spree in 2nd Quarter Jul 01 / GuruFocus News - Paid Partner Content | BD (BDX) Integrates Innovative Solution to Boost Patient Care Jun 23 / Zacks.com - Paid Partner Content |
BD's (BDX) New Combination Test to Boost Patient Outcome Jul 01 / Zacks.com - Paid Partner Content |
Previous close | 247.93 |
Today’s open | 249.55 |
Day’s range | 243.87 - 250.14 |
Volume | 777,657 |
Average volume (3 months) | 1,188,883 |
Market cap | $71.8B |
Earnings growth (last year) | +151.71% |
Earnings growth (this year) | -11.30% |
Earnings growth (next 5 years) | +6.63% |
Revenue growth (last year) | +18.29% |
P/E ratio | 39.0 |
Price/Sales | 3.55 |
Price/Book | 3.03 |
Today’s change | Today’s % change | |
---|---|---|
BSXBoston Scientific Co... | +0.01 | +0.03% |
BAXBaxter International... | +0.01 | +0.02% |
DXCMDexcom Inc | +0.83 | +1.07% |
WSTWest Pharmaceutical ... | -0.04 | -0.01% |
Next reporting date | August 4, 2022 |
EPS forecast (this quarter) | $2.50 |
Annual revenue (last year) | $20.2B |
Annual profit (last year) | $2.1B |
Net profit margin | 10.33% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |